Global Veterinary Pharmacovigilance Market
The Veterinary Pharmacovigilance market, valued at USD 0.78 billion in 2022, is expected to reach USD 1.89 billion by 2030, with a CAGR of 11.34 % during the forecast period 2023-2030.
Veterinary pharmacovigilance is the monitoring, assessment, and improvement of the safety of veterinary drugs, with a focus on adverse events in animals and people associated with their use.
Market Drivers
Increasing approvals of veterinary pharmaceutical products, knowledge of and need for veterinary Pharmacovigilance reporting, the requirement for regulatory compliance, and activities by both public and private market participants are some of the major drivers influencing the industry's growth. The EMA's recommendations for veterinary good pharmacovigilance practices took effect in Europe in January 2022. These emphasise continuous signal management, the upkeep of a master pharmacovigilance file by the holder of the marketing authorization, and regulatory pharmacovigilance inspections.
Covid Impact -19
In order to safeguard both human and animal health, the COVID-19 pandemic helped raise awareness about the significance of pharmacovigilance reporting. Additionally, it sped up the adoption of and shift to electronic reporting systems and software by end users like veterinary CROs, manufacturers, etc. For instance, Indivirtus provides a variety of veterinary vigilance services to customers like Alivira Animal Health Limited.
Market Segmentation
Global Veterinary Pharmacovigilance Market is segmented into By Solution, By Product, and By Animal Type.
Based on the By Solution market is segment into Software, Services. Further market is segment into By Product market is segment into Biologics, Anti-infectives, Other. By Animal Type market is segmented into Dogs, Cats, Other Animal Types.
Regional Analysis
Global Veterinary Pharmacovigilance Market is segmented into five main regions, namely, North America, Europe, Asia Pacific, Middle East and Africa, and Latin America. North America dominated the Veterinary Pharmacovigilance processor industry. Die wachsende Regelung des Gebrauchs von Tiermedikamenten ist ein wichtiger Faktor. The Rational Questionnaire (RQ) in the Safety Reporting Portal (SRP) and the Electronic Submissions System (ESS) is used by the FDA's Center for Veterinary Medicine (CVM) to accept electronic submissions of adverse events for veterinary drugs. Die ständige Überwachung von genehmigten NADAs und ANADAs ermöglicht der FDA, potenzielle Risiken in Bezug auf die Sicherheit und Wirksamkeit von neu genehmigten und vertriebenen Tiermedikamenten sowie mögliche Probleme in Bezug auf Produkte und die Herstellung.
Key Players
Various key players are listed in this report such as ArisGlobal, Accenture, Ennov, Sarjen Systems Pvt. Ltd., Pharsafer Associates Limited, Knoel, Indivirtus, Azierta Contract Science Support Consulting, Oy Medfiles Ltd.
Market Taxonomy
By Solution
• Software
• Services
By Product
• Biologics
• Anti-infectives
• Other
By Animal Type
• Dogs
• Cats
• Other Animal Types
By Region
• North America
o U.S.
o Canada
o Mexico
• Latin America
o Brazil
o Argentina
o Colombia
o Peru
o Chile
o Venezuela
o Rest of Latin America
• Europe
o Germany
o France
o UK
o Russia
o Italy
o Spain
o Rest of Europe
• Asia Pacific
o China
o Japan
o India
o South Korea
o Australia
o New Zealand
o Singapore
o Malaysia
o Rest of Asia Pacific
• Middle East & Africa
o Saudi Arabia
o UAE
o Egypt
o Kuwait
o South Africa
o Rest Middle East & Africa
Key Questions Addressed by the Report
• What are the Key Opportunities in Global Veterinary Pharmacovigilance Market?
• What will be the growth rate from 2023 to 2030?
• Which segment/region will have highest growth?
• What are the factors that will impact/drive the Market?
• What is the competitive Landscape in the Industry?
• What is the role of key players in the value chain?
Global Veterinary Pharmacovigilance Market
1 Introduction
1.1 Objective of the Study
1.2 Market Definition
1.3 Market Scope
2 Research Methodology
2.1 Data Mining
2.2 Validation
2.3 Primary Interviews
2.4 List of Data Sources
3 Executive Summary
4 Global Veterinary Pharmacovigilance Market Outlook
4.1 Overview
4.2 Market Dynamics
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.2.4 Cumulative Impact due to recent Energy Crisis
4.2.5 Cumulative Impact due to nearing economic downturn.
4.2.6 Post covid-19 world Supply& Demand conditions
4.2.7 Cumulative Impact of Russia-Ukraine Conflict
4.3 Porters Five Force Model
4.4 Value Chain Analysis
5 Global Veterinary Pharmacovigilance Market, By Solution
5.1 Y-o-Y Growth Comparison, By Solution
5.2 Global Veterinary Pharmacovigilance Market Share Analysis, By Solution
5.3 Global Veterinary Pharmacovigilance Market Size and Forecast, By Solution
5.3.1 Software
5.3.2 Services
6 Global Veterinary Pharmacovigilance Market, By Product
6.1 Y-o-Y Growth Comparison, By Product
6.2 Global Veterinary Pharmacovigilance Market Share Analysis, By Product
6.3 Global Veterinary Pharmacovigilance Market Size and Forecast, By Product
6.3.1 Biologics
6.3.2 Anti-infectives
6.3.3 Other
7 Global Veterinary Pharmacovigilance Market, By Animal Type
7.1 Y-o-Y Growth Comparison, By Animal Type
7.2 Global Veterinary Pharmacovigilance Market Share Analysis, By Animal Type
7.3 Global Veterinary Pharmacovigilance Market Size and Forecast, By Animal Type
7.3.1 Dogs
7.3.2 Cats
7.3.3 Other Animal Types
8 Global Veterinary Pharmacovigilance Market, By Region
8.1 Global Veterinary Pharmacovigilance Market Share Analysis, By Region
8.2 Global Veterinary Pharmacovigilance Market Size and Forecast, By Region
8.3 Global Veterinary Pharmacovigilance Market Trends and Forecast, By Region
9 North America Veterinary Pharmacovigilance Market Analysis and Forecast (2023-2030)
9.1 Introduction
9.2 North America Veterinary Pharmacovigilance Market Share Analysis, By Solution
9.3 North America Veterinary Pharmacovigilance Market Size and Forecast, By Product
9.4 North America Veterinary Pharmacovigilance Market Size and Forecast, By Animal Type
9.5 North America Veterinary Pharmacovigilance Market Size and Forecast, By Country
9.5.1 U.S.
9.5.1.1. Market Size and Forecast, By Solution
9.5.1.2 Market Size and Forecast, By Product
9.5.1.3. Market Size and Forecast, By Animal Type
9.5.2 Canada
9.5.2.1. Market Size and Forecast, By Solution
9.5.2.2 Market Size and Forecast, By Product
9.5.2.3. Market Size and Forecast, By Animal Type
9.5.3 Mexico
9.5.3.1. Market Size and Forecast, By Solution
9.5.3.2 Market Size and Forecast, By Product
9.5.3.3. Market Size and Forecast, By Animal Type
10 Europe Veterinary Pharmacovigilance Market Analysis and Forecast (2023-2030)
10.1 Introduction
10.2 Europe Veterinary Pharmacovigilance Market Share Analysis, By Solution
10.3 Europe Veterinary Pharmacovigilance Market Size and Forecast, By Product
10.4 Europe Veterinary Pharmacovigilance Market Size and Forecast, By Animal Type
10.5 Europe Veterinary Pharmacovigilance Market Size and Forecast, By Country
10.5.1 Germany
10.5.1.1. Market Size and Forecast, By Solution
10.5.1.2 Market Size and Forecast, By Product
10.5.1.3. Market Size and Forecast, By Animal Type
10.5.2 France
10.5.2.1. Market Size and Forecast, By Solution
10.5.2.2 Market Size and Forecast, By Product
10.5.2.3. Market Size and Forecast, By Animal Type
10.5.3 UK
10.5.3.1. Market Size and Forecast, By Solution
10.5.3.2 Market Size and Forecast, By Product
10.5.3.3. Market Size and Forecast, By Animal Type
10.5.4. Russia
10.5.4.1. Market Size and Forecast, By Solution
10.5.4.2 Market Size and Forecast, By Product
10.5.4.3. Market Size and Forecast, By Animal Type
10.5.5. Italy
10.5.5.1. Market Size and Forecast, By Solution
10.5.5.2 Market Size and Forecast, By Product
10.5.5.3. Market Size and Forecast, By Animal Type
10.5.6. Spain
10.5.6.1. Market Size and Forecast, By Solution
10.5.6.2 Market Size and Forecast, By Product
10.5.6.3. Market Size and Forecast, By Animal Type
10.5.7. Rest of Europe
10.5.7.1. Market Size and Forecast, By Solution
10.5.7.2 Market Size and Forecast, By Product
10.5.7.3. Market Size and Forecast, By Animal Type
11 Asia Pacific Veterinary Pharmacovigilance Market Analysis and Forecast (2023-2030)
11.1 Introduction
11.2 Asia Pacific Veterinary Pharmacovigilance Market Share Analysis, By Solution
11.3 Asia Pacific Veterinary Pharmacovigilance Market Size and Forecast, By Product
11.4 Asia Pacific Veterinary Pharmacovigilance Market Size and Forecast, By Animal Type
11.5 Asia Pacific Veterinary Pharmacovigilance Market Size and Forecast, By Country
11.5.1 China
11.5.1.1. Market Size and Forecast, By Solution
11.5.1.2 Market Size and Forecast, By Product
11.5.1.3. Market Size and Forecast, By Animal Type
11.5.2 Japan
11.5.2.1. Market Size and Forecast, By Solution
11.5.2.2 Market Size and Forecast, By Product
11.5.2.3. Market Size and Forecast, By Animal Type
11.5.3 India
11.5.3.1. Market Size and Forecast, By Solution
11.5.3.2 Market Size and Forecast, By Product
11.5.3.3. Market Size and Forecast, By Animal Type
11.5.4. South Korea
11.5.4.1. Market Size and Forecast, By Solution
11.5.4.2 Market Size and Forecast, By Product
11.5.4.3. Market Size and Forecast, By Animal Type
11.5.5. Australia
11.5.5.1. Market Size and Forecast, By Solution
11.5.5.2 Market Size and Forecast, By Product
11.5.5.3. Market Size and Forecast, By Animal Type
11.5.6. New Zealand
11.5.6.1. Market Size and Forecast, By Solution
11.5.6.2 Market Size and Forecast, By Product
11.5.6.3. Market Size and Forecast, By Animal Type
11.5.7. Singapore
11.5.7.1. Market Size and Forecast, By Solution
11.5.7.2 Market Size and Forecast, By Product
11.5.7.3. Market Size and Forecast, By Animal Type
11.5.8. Malaysia
11.5.8.1. Market Size and Forecast, By Solution
11.5.8.2 Market Size and Forecast, By Product
11.5.8.3. Market Size and Forecast, By Animal Type
11.5.9. Rest of Asia
11.5.9.1. Market Size and Forecast, By Solution
11.5.9.2 Market Size and Forecast, By Product
11.5.9.3. Market Size and Forecast, By Animal Type
12 Latin America Veterinary Pharmacovigilance Market Analysis and Forecast (2023-2030)
12.1 Introduction
12.2 Latin America Veterinary Pharmacovigilance Market Share Analysis, By Solution
12.3 Latin America Veterinary Pharmacovigilance Market Size and Forecast, By Product
12.4 Latin America Veterinary Pharmacovigilance Market Size and Forecast, By Animal Type
12.5 Latin America Veterinary Pharmacovigilance Market Size and Forecast, By Country
12.5.1 Brazil
12.5.1.1. Market Size and Forecast, By Solution
12.5.1.2 Market Size and Forecast, By Product
12.5.1.3. Market Size and Forecast, By Animal Type
12.5.2 Argentina
12.5.2.1. Market Size and Forecast, By Solution
12.5.2.2 Market Size and Forecast, By Product
12.5.2.3. Market Size and Forecast, By Animal Type
12.5.3. Colombia
12.5.3.1. Market Size and Forecast, By Solution
12.5.3.2 Market Size and Forecast, By Product
12.5.3.3. Market Size and Forecast, By Animal Type
12.5.4. Peru
12.5.4.1. Market Size and Forecast, By Solution
12.5.4.2 Market Size and Forecast, By Product
12.5.4.3. Market Size and Forecast, By Animal Type
12.5.5. Chile
12.5.5.1. Market Size and Forecast, By Solution
12.5.5.2 Market Size and Forecast, By Product
12.5.5.3. Market Size and Forecast, By Animal Type
12.5.6. Venezuela
12.5.6.1. Market Size and Forecast, By Solution
12.5.6.2 Market Size and Forecast, By Product
12.5.6.3. Market Size and Forecast, By Animal Type
12.5.7. Rest of Latin America
12.5.7.1. Market Size and Forecast, By Solution
12.5.7.2 Market Size and Forecast, By Product
12.5.7.3. Market Size and Forecast, By Animal Type
13 Middle East Veterinary Pharmacovigilance Market Analysis and Forecast (2023-2030)
13.1 Introduction
13.2 Middle East Veterinary Pharmacovigilance Market Share Analysis, By Solution
13.3 Middle East Veterinary Pharmacovigilance Market Size and Forecast, By Product
13.4 Middle East Veterinary Pharmacovigilance Market Size and Forecast, By Animal Type
13.5 Middle East Veterinary Pharmacovigilance Market Size and Forecast, By Country
13.5.1. Saudi Arabia
13.5.1.1. Market Size and Forecast, By Solution
13.5.1.2 Market Size and Forecast, By Product
13.5.1.3. Market Size and Forecast, By Animal Type
13.5.2 UAE
13.5.2.1. Market Size and Forecast, By Solution
13.5.2.2 Market Size and Forecast, By Product
13.5.2.3. Market Size and Forecast, By Animal Type
13.5.3 Egypt
13.5.3.1. Market Size and Forecast, By Solution
13.5.3.2 Market Size and Forecast, By Product
13.5.3.3. Market Size and Forecast, By Animal Type
13.5.4 Kuwait
13.5.4.1. Market Size and Forecast, By Solution
13.5.4.2 Market Size and Forecast, By Product
13.5.4.3. Market Size and Forecast, By Animal Type
13.5.5 South Africa
13.5.5.1. Market Size and Forecast, By Solution
13.5.5.2 Market Size and Forecast, By Product
13.5.5.3. Market Size and Forecast, By Animal Type
13.5.6 Rest of Middle East & Africa
13.5.6.1. Market Size and Forecast, By Solution
13.5.6.2 Market Size and Forecast, By Product
13.5.6.3. Market Size and Forecast, By Animal Type
14 Competitive Analysis
14.1 Competition Dashboard
14.2 Market share Analysis of Top Vendors
14.3 Key Development Strategies
15 Company Profiles
15.1 ArisGlobal
15.1.1 Overview
15.1.2 Offerings
15.1.3 Key Financials
15.1.4 Business Segment & Geographic Overview
15.1.5 Key Market Developments
15.1.6 Key Strategies
15.2 Accenture
15.2.1 Overview
15.2.2 Offerings
15.2.3 Key Financials
15.2.4 Business Segment & Geographic Overview
15.2.5 Key Market Developments
15.2.6 Key Strategies
15.3. Ennov
15.3.1 Overview
15.3.2 Offerings
15.3.3 Key Financials
15.3.4 Business Segment & Geographic Overview
15.3.5 Key Market Developments
15.3.6 Key Strategies
15.4. Sarjen Systems Pvt. Ltd.
15.4.1 Overview
15.4.2 Offerings
15.4.3 Key Financials
15.4.4 Business Segment & Geographic Overview
15.4.5 Key Market Developments
15.4.6 Key Strategies
15.5 Pharsafer Associates Limited
15.5.1 Overview
15.5.2 Offerings
15.5.3 Key Financials
15.5.4 Business Segment & Geographic Overview
15.5.5 Key Market Developments
15.5.6 Key Strategies
15.6 Knoell
15.6.1 Overview
15.6.2 Offerings
15.6.3 Key Financials
15.6.4 Business Segment & Geographic Overview
15.6.5 Key Market Developments
15.6.6 Key Strategies
15.7 Indivirtus
15.7.1 Overview
15.7.2 Offerings
15.7.3 Key Financials
15.7.4 Business Segment & Geographic Overview
15.7.5 Key Market Developments
15.7.6 Key Strategies
15.8 Azierta Contract Science Support Consulting
15.8.1 Overview
15.8.2 Offerings
15.8.3 Key Financials
15.8.4 Business Segment & Geographic Overview
15.8.5 Key Market Developments
15.8.6 Key Strategies
15.9 Oy Medfiles Ltd
15.9.1 Overview
15.9.2 Offerings
15.9.3 Key Financials
15.9.4 Business Segment & Geographic Overview
15.9.5 Key Market Developments
15.9.6 Key Strategies
15.10 Carestream Health
15.10.1 Overview
15.10.2 Offerings
15.10.3 Key Financials
15.10.4 Business Segment & Geographic Overview
15.10.5 Key Market Developments
15.10.6 Key Strategies
